Cornerstone Capital Management Holdings’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$145K Sell
11,471
-99,229
-90% -$1.31M ﹤0.01% 1143
2017
Q3
$1.57M Buy
110,700
+30,200
+38% +$378K 0.01% 830
2017
Q2
$1.04M Buy
80,500
+59,500
+283% +$767K 0.01% 901
2017
Q1
$301K Sell
21,000
-13,500
-39% -$199K ﹤0.01% 1124
2016
Q4
$538K Buy
34,500
+8,200
+31% +$112K ﹤0.01% 1073
2016
Q3
$309K Sell
26,300
-26,400
-50% -$348K ﹤0.01% 1141
2016
Q2
$734K Sell
52,700
-42,300
-45% -$561K 0.01% 952
2016
Q1
$1.1M Buy
95,000
+30,200
+47% +$384K 0.01% 887
2015
Q4
$1.06M Buy
+64,800
New +$1.03M 0.01% 882

Other funds holding CCRN

Cornerstone Capital Management Holdings's CCRN Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Cross Country Healthcare (CCRN) stake by 90% in Q4 2017, selling an estimated $1.31M and leaving 11,471 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Cornerstone Capital Management Holdings first reported a position in CCRN in Q4 2015 and has held it in 9 quarters since. The position peaked at $1.57M in Q3 2017. 144 funds tracked by Wall St. Rank hold CCRN as of Q4 2017.

  • Cornerstone Capital Management Holdings held 11,471 shares of Cross Country Healthcare worth $145K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 99,229 Cross Country Healthcare shares in Q4 2017, an estimated $1.31M.
  • Cross Country Healthcare made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1143 holding.
  • Cornerstone Capital Management Holdings first reported a position in Cross Country Healthcare in Q4 2015 and has held it in 9 quarters since.
  • Cornerstone Capital Management Holdings's Cross Country Healthcare position peaked at $1.57M in Q3 2017.
  • 144 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.